title: An Australasian perspective on sarcoma research, translational biology and clinical trials: the Australasian Sarcoma Study Group (ASSG).
abstract: Each year approximately 800 Australians are diagnosed with sarcoma, accounting for less than 1% of cancer diagnoses overall. A significant proportion of these sarcoma cases are in children and adolescents. The rarity and heterogeneity of this group of tumours, coupled with Australasia's relative geographical isolation, pose significant challenges in developing locoregional basic, translational and clinical research. The Australasian Sarcoma Study Group (ASSG) was established in 2008 as a Cooperative Cancer Clinical Research Group and is now the peak body for sarcoma research in Australasia, providing a mechanism to drive and coordinate collaborative research, promote education and assist with advocating for sarcoma within the region. This paper describes the development of ASSG and examines the current state of play with regard to sarcoma research in Australasia.
authors.affiliation: 1Australasian Sarcoma Study Group (ASSG) 2Peter MacCallum Cancer Centre 3Royal Melbourne Hospital, Melbourne, Victoria, Australia.
authors.forename: Susie
authors.initials: S
authors.lastname: Bae
authors.forename: Denise
authors.initials: D
authors.lastname: Caruso
authors.forename: Jayesh
authors.initials: J
authors.lastname: Desai
mesh_terms: D001315:Australia / Q000453:epidemiology; D035843:Biomedical Research / Q000639:trends*; D002986:Clinical Trials as Topic; D006801:Humans; D012109:Research Support as Topic / Q000639:trends; D012509:Sarcoma / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D057170:Translational Research, Biomedical